G
Guillermo Torre-Amione
Researcher at Baylor College of Medicine
Publications - 121
Citations - 8177
Guillermo Torre-Amione is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: Heart failure & Transplantation. The author has an hindex of 41, co-authored 110 publications receiving 7843 citations. Previous affiliations of Guillermo Torre-Amione include Houston Methodist Hospital.
Papers
More filters
Clinical Trials Early Worsening Heart Failure in Patients Admitted for Acute Heart Failure: Time Course, Hemodynamic Predictors, and Outcome
Guillermo Torre-Amione,Olga Milo-Cotter,Edo Kaluski,Loïc Perchenet,Isaac Kobrin,Aline Frey,Michele M. Rund,Beth Davison Weatherley,Gad Cotter +8 more
TL;DR: Worsening hear failure (WHF) is a new outcome measure that incorporates failure to improve or recurrent symptoms of acute heart failure requiring rescue intravenous therapy, mechanical circulatory or ventilatory support, or readmission because of AHF, occurring within 30 days of admission as mentioned in this paper.
Patent
Traitement de la myocardite
TL;DR: Une inflammation cardiaque, illustree par la myocardite chez un patient mammifere, est attenuee par un procede qui consiste a: extraire une aliquote de sang du patient; effectuer un traitement extracorporel de l'aliquote par exposition a une contrainte oxydative and a une emission electromagnetique.
Journal ArticleDOI
Cannabidiol therapy for chronic heart failure prevents cardiac pathological remodeling in a non-ischemic cardiomyopathy murine model
Omar Lozano,Gerardo García-Rivas,Martín Ramos,Christian Silva Platas,Judith Bernal-Ramírez,Eduardo Vázquez-Garza,Guillermo Torre-Amione +6 more
Journal ArticleDOI
Reversal of pulmonary hypertension with LVAD therapy
Megan P. Tierney,Robert E. Southard,David L. Joyce,George P. Noon,Mathias Loebe,Michael M. Koerner,Guillermo Torre-Amione +6 more
Patent
Electrocardiographic aspects of chf treatment
TL;DR: In this article, it has been found that prolonged QT-c intervals in mammalian patients, indicative of susceptibility of the patients to arrhythmia and sudden cardiac death, can be reduced by a process in which an aliquot of the patient's blood is removed and stressed extracorporeally, by application of oxidative stress and electromagnetic radiation such as ultraviolet light, and then re-injected into the patient.